ArticleFrontiers in oncology2025
Well-differentiated HPV-independent gastric-type adenocarcinoma of the cervix: a case report and literature review.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Well-differentiated HPV-independent gastric-type endocervical adenocarcinoma (formerly termed minimal deviation adenocarcinoma) is a rare, aggressive cervical cancer that is challenging to diagnose because its histologic features can be very similar to benign endocervical glands or even normal glands. The imaging features and clinical manifestations are also non-specific, with the disease often having an insidious onset. However, this tumor exhibits a high degree of aggressiveness and tends to progress rapidly; as a result, it is frequently diagnosed at an advanced stage, missing the optimal window for treatment. Therefore, thorough investigations are required to identify specific pathological features unique to this condition to improve imaging and the early diagnosis rate. Case introduction: This article reports a case of a 42-year-old female patient who was hospitalized for 2 months due to vaginal discharge and 1 week of lower abdominal pain. Upon physical examination, a small amount of odorless, transparent secretion was detected in the vagina; the cervix appeared enlarged, and a mass measuring approximately 6 cm was palpable in the right adnexal region. The pelvic MRI indicated the presence of malignant cervical lesions, potentially cervical gastric-type adenocarcinoma, accompanied by significant pericervical invasion. Colposcopy also suggested the presence of cervical adenocarcinoma. Following the exclusion of any surgical contraindications, robotic-assisted laparoscopic extensive hysterectomy and bilateral adnexectomy were performed under general anesthesia. Postoperative pathological examination confirmed the presence of invasive cervical adenocarcinoma, independent of HPV. The subtype identified was classified as gastric-type adenocarcinoma, exhibiting locally well-differentiated characteristics. Conclusion: Highly differentiated HPV-independent cervical gastric-type adenocarcinoma is insidious in onset and progresses rapidly. Clinically, it often presents with abnormal vaginal discharge or bleeding, and deep biopsy or cervical conization is often required for diagnosis. Pathologically, it is characterized by randomly distributed, highly differentiated tumoral glands, which often invade deep into the uterine wall, extending beyond 2/3 of the cervical wall. It also shows positive expression of gastric-type markers such as MUC6, Mucin 5AC, and HIK1083. Imaging examination revealed the size of the lesion, depth of infiltration, the invasion of adjacent organs, and lymph node metastasis, which is beneficial for differential diagnosis, clinical staging, and the development of a treatment plan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.